Status:
COMPLETED
New Magnesium Sulphate Protocol for Pre-eclampsia
Lead Sponsor:
Cairo University
Conditions:
Pre-eclampsia
Eligibility:
FEMALE
18-42 years
Phase:
PHASE3
Brief Summary
there is a standard magnesium sulphate protocol and newer protocols for pre-eclampsia, we need to make a trial to find the best protocol
Detailed Description
The aim of our study is to assess the comparative effects of three regimens for the administration of magnesium sulfate when used for the care of women with severe pre-eclampsia. The study will inclu...
Eligibility Criteria
Inclusion
- Pregnant females ≥20 weeks of gestation.
- Pregnant females with criteria of severe pre-eclampsia.
- Single or multi-fetal pregnancy.
- Primigravida or Multigravida.
Exclusion
- Pregnant females \< 20 weeks gestation.
- Pregnant females with history of epilepsy.
- Pregnant females with diabetes.
- Pregnant females with chronic hypertension.
- Pregnant females with renal disease.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01846156
Start Date
May 1 2013
End Date
April 1 2014
Last Update
August 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy hospital
Cairo, Cairo Governorate, Egypt, 12311